Ten unanswered questions about dipeptidyl peptidase-1 inhibition in bronchiectasis - PubMed
4 hours ago
- #bronchiectasis
- #DPP-1 inhibition
- #medical research
- The article discusses ten unanswered questions regarding dipeptidyl peptidase-1 (DPP-1) inhibition in bronchiectasis.
- JDC has received consulting fees from multiple pharmaceutical companies including AstraZeneca, Chiesi, GSK, and others.
- JDC has also received grants or contracts from companies like AstraZeneca, Genentech, and Boehringer Ingelheim.
- MBL has received consulting fees from Grifols.
- The other authors have declared no competing interests.